04
Jun
2025
Redcare Pharmacy: Statement on today’s media coverage regarding CardLink.
»
16
May
2025
Redcare Pharmacy's Annual General Meeting 2025: All agenda items approved; Michael Köhler and Stephan Weber new members of the Supervisory Board.
»
06
May
2025
Strong Q1 performance for Redcare Pharmacy: back to a positive margin while maintaining fast growth.
»
08
Apr
2025
Redcare successfully executes placement of new convertible bonds and buys back part of the outstanding convertible bonds.
»
04
Apr
2025
Redcare Pharmacy: fast growth continues in Q1; fully-organic sales growth 28%, Rx sales in Germany up 191% and active customers up 0.6 million.
»
02
Apr
2025
Michael Köhler and Stephan Weber nominated for the Supervisory Board of Redcare Pharmacy.
»
11
Mar
2025
Building on a successful 2024, Redcare Pharmacy expects margin uplift and unabated fast growth in 2025, including a doubling of Rx.
»
27
Feb
2025
 Positive judgment of the European Court of Justice strengthens the position of Redcare Pharmacy and its customers.
»
09
Jan
2025
Redcare Pharmacy completes an exceptional year across the Group: 2024 sales up 32% to EUR 2.4bn, with Rx growth in Germany accelerating to 142% in Q4.
»
05
Nov
2024
Redcare Pharmacy: strong Q3 growth combined with 2% adj. EBITDA margin. Rx momentum in Germany further increased, with sales growth of over 130% in October.
»